Cancer Detection and Diagnosis Research in Puerto Rico
Cancer Detection and Diagnosis Research (93.394) awarded $3.1 million to recipients in Puerto Rico in 3 grants from fiscal 2021 to 2025, 0.1% of the program's national total. Lifegene- Biomarks Inc received the most, $3.6 million.
- Awarded in Puerto Rico$3.1 million
- Awards3
- Share of the program0.1%
- Rank among states41st of 45
- National total$2.7 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 1 | $399,998 |
| FY 2022 | 1 | $1.0 million |
| FY 2023 | 2 | $1.3 million |
| FY 2024 | 1 | $6,000 |
| FY 2025 | 1 | $401,587 |
Recipients in Puerto Rico
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Lifegene- Biomarks Inc | Small businesses | 2 | $3.6 million |
| Universidad Central del Caribe, Inc | Colleges and universities | 1 | $6,000 |
Open opportunities under this program
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
- Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)
- Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
See all 47 on the program page
Questions people ask
How much Cancer Detection and Diagnosis Research money goes to Puerto Rico?
$3.1 million from fiscal 2021 to 2025, across 3 awards. Puerto Rico ranks 41st of 45 states and territories for this program.
Who receives Cancer Detection and Diagnosis Research money in Puerto Rico?
The largest recipient is Lifegene- Biomarks Inc, with $3.6 million in 2 awards. Next is Universidad Central del Caribe, Inc.
Can organizations in Puerto Rico apply now?
Yes, 47 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Detection and Diagnosis Research in other states
Other large programs in Puerto Rico
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Community Development Block Grants/State's program and Non-Entitlement Grants in Hawaii
- Grants to States for Medicaid
- Education Stabilization Fund
- Title I Grants to Local Educational Agencies
- Head Start
- Public Housing Operating Fund
- Highway Planning and Construction
- Pandemic EBT Food Benefits
- WIC Special Supplemental Nutrition Program for Women, Infants, and Children